Podcast: Play in new window | Download (Duration: 57:33 — 39.5MB) | Embed
Subscribe: Android | Email | RSS | More
From humble beginnings in Edinburgh, Martin Mackay PhD’s lifelong passion for football and his beloved Heart of Midlothian, allied to a total fascination with the ‘coolness’ of lab coats, were parlayed into a hugely impressive career, including major research leadership roles at industry titans such as Pfizer, AstraZeneca and Alexion. Now, “having a blast” in the world of biotech with Rallybio, he still also exerts his influence and experience on big corporates via board seats at Novo Nordisk and Charles River Labs.
Martin points to his current experience of leading a biotech: “At Rallybio, sitting here in Connecticut, our first five deals were consecutively in Norway, Sweden, the UK, France and Canada! It points to our heritage that we are willing to look anywhere for great assets and programs.”
When Martin considers the UK’s importance in the life science universe he asserts: “No question, the UK is a good place to do business and we will continue to go back there where it is appropriate to do so... I am confident that future UK governments will continue to be supportive towards life science institutions across the UK. It is a great place to do science and to grow.”